Stay informed with the latest litigation news. Explore now

Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc - 2:23-cv-03531

Explore the details of the Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc case under case number 2:23-cv-03531 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:23-cv-03531
Filing Date
Jun 29, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD. -
BOEHRINGER INGELHEIM INTERNATIONAL GMBH -
ANOBRI PHARMACEUTICALS US, LLC -
PHV SCOTT A. CUNNING -
NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. -

Patents Involved

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US7896264B2
-US7284474B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 28, 2023Letter from Boehringer to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 11/28/2023)PACER Document
Nov 29, 2023LETTER ORDER granting the parties' request for an extension until 12/12/2023 of time to submit a proposed Discovery Confidentiality Order. Signed by Magistrate Judge Leda D. Wettre on 11/29/2023. (mxw, ) (Entered: 11/29/2023)PACER Document
Dec 8, 2023Letter from Boehringer to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 12/08/2023)PACER Document
Dec 11, 2023Letter from Eric Abraham to the Honorable Judge Leda Wettre U.S.M.J. with Proposed Order. (MURTHA, WILLIAM) (Entered: 12/11/2023)PACER Document
Dec 14, 2023LETTER ORDER granting the parties' request for a one-week extension to submit a proposed Discovery Confidentiality Order until 12/19/2023. Signed by Magistrate Judge Leda D. Wettre on 12/14/2023. (sm) (Entered: 12/14/2023)PACER Document
Dec 15, 2023Letter from Boehringer to the Hon. Claire C. Cecchi, U.S.D.J.. (LIZZA, CHARLES) (Entered: 12/15/2023)PACER Document
Dec 18, 2023STIPULATED CONSOLIDATION ORDER that Civil Action Nos. 23-3530 and 23-3531 (the Consolidated Actions) are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; all filings in the Consolidated Actions shall use the above caption on this Order; that all filings going forward that are common to Civil Action Nos. 23-3530 and 23-2331 shall be filed in Civil Action No. 23-3530, and that Civil Action No. 23-3531 shall be terminated by the Clerks office for administrative purposes only. Signed by Judge Claire C. Cecchi on 12/18/2023. (sm) (Entered: 12/18/2023)PACER Document
Mar 20, 2024Letter from Defendant, Anobri Pharmaceuticals to Judge Wettre Requesting Withdrawal of Pro Hac Vice of C. Kyle Musgrove. (ABRAHAM, ERIC) (Entered: 03/20/2024)PACER Document
Mar 20, 2024LETTER ORDER that C. Kyle Musgrove is withdrawn as pro hac vice counsel. KYLE C. MUSGROVE terminated. Signed by Magistrate Judge Leda D. Wettre on 3/20/2024. (sm) (Entered: 03/20/2024)PACER Document
Jul 24, 2024STIPULATION OF DISMISSAL OF CLAIMS, COUNTERCLAIMS, ANDAFFIRMATIVE DEFENSES REGARDING U.S. PATENT NOS. 7,284,474 AND 7,896,264 without prejudice. Signed by Judge Claire C. Cecchi on 7/24/2024. (sm) (Entered: 07/24/2024)PACER Document
Jun 29, 2023Case Assigned to Judge Claire C. Cecchi and Magistrate Judge Michael A. Hammer. (ak, )PACER Document
Aug 31, 2023Clerk`s Text Order - The document 11 submitted by ANOBRI PHARMACEUTICALS US, LLC has been GRANTED. The answer due date has been set for 9/12/2023. (sm)PACER Document
Sep 27, 2023Clerk`s Text Order - The document 14 submitted by BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. has been GRANTED. The answer due date has been set for 10/17/2023. (sm)PACER Document
Oct 2, 2023Case Reassigned to Magistrate Judge Leda D. Wettre. Magistrate Judge Michael A. Hammer no longer assigned to the case. (ak, )PACER Document
Oct 12, 2023Set Deadlines as to 16 MOTION for Leave to Appear Pro Hac Vice C. Kyle Musgrove, Esq.. Motion set for 11/6/2023 before Judge Claire C. Cecchi. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm)PACER Document
Oct 13, 2023Set Deadlines as to 17 MOTION for Leave to Appear Pro Hac Vice Elizabeth M. Crompton, Esq.. Motion set for 11/6/2023 before Judge Claire C. Cecchi. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm)PACER Document
Nov 13, 2023Set Deadlines as to 26 MOTION for Leave to Appear Pro Hac Vice Scott Cunning, Esq.. Motion set for 12/18/2023 before Judge Claire C. Cecchi. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm)PACER Document
Nov 14, 2023Minute Entry for proceedings held before Magistrate Judge Leda D. Wettre: Initial Pretrial Conference held on 11/14/2023. (LM, )PACER Document
Dec 18, 2023***Civil Case Terminated. (sm)PACER Document